Clinical Trials in Daegu, South Korea
Locations / Daegu, South Korea
Delta Trials lists 2,036 clinical trials conducted in Daegu, South Korea, making it a notable site of clinical research activity. These trials addressing 1,365 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 169 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Daegu research landscape.
2036
Total Trials
1365
Conditions
169
Terminated since 2020
Browse by condition (1365 total)
- Coronary artery disease 70 trialsAll Coronary artery disease trials
- Crohn's disease 51 trialsAll Crohn's disease trials
- Ulcerative colitis 51 trialsAll Ulcerative colitis trials
- Gastric cancer 47 trialsAll Gastric cancer trials
- Breast cancer 40 trialsAll Breast cancer trials
- Rheumatoid arthritis 39 trialsAll Rheumatoid arthritis trials
- Diabetes mellitus, type 2 38 trialsAll Diabetes mellitus, type 2 trials
- Hypertension 31 trialsAll Hypertension trials
- Non-small cell lung cancer 30 trialsAll Non-small cell lung cancer trials
- Atrial fibrillation 29 trialsAll Atrial fibrillation trials
- Asthma 27 trialsAll Asthma trials
- Chronic hepatitis b 23 trialsAll Chronic hepatitis b trials
- Hepatocellular carcinoma 21 trialsAll Hepatocellular carcinoma trials
- Acute coronary syndrome 21 trialsAll Acute coronary syndrome trials
- Colitis, ulcerative 21 trialsAll Colitis, ulcerative trials
- Multiple myeloma 18 trialsAll Multiple myeloma trials
- Epilepsy 17 trialsAll Epilepsy trials
- Type 2 diabetes mellitus 16 trialsAll Type 2 diabetes mellitus trials
- Heart failure 16 trialsAll Heart failure trials
- Systemic lupus erythematosus 16 trialsAll Systemic lupus erythematosus trials